FDA gives breakthrough status to Biofourmis’ heart failure DTxA digital therapeutic for patients with heart failure has been awarded breakthrough device status by the FDA – Share XFDA gives breakthrough status to Biofourmis’ heart failure DTxhttps://pharmaphorum.com/news/fda-gives-breakthrough-status-to-biofourmis-heart-failure-dtx/
FDA Breakthrough Device Designation for blood infection testThe FDA’s drive to accelerate access to new medical device technologies continues, with a new product from 3i Share XFDA Breakthrough Device Designation for blood infection testhttps://pharmaphorum.com/news/fda-breakthrough-device-designation-blood-infection-test/
